You are here: Industry Insights > GlobalData

News List

China’s blockchain-backed recovery from COVID-19 could pave way for efficient disease surveillance s expresspharma
May 06, 2020
After the SARS epidemic hit the country, the Chinese Center for Disease Control and Prevention implemented a new nationwide web-based automated system (CIDARS) to assure timely response to outbreak detection and prevention.
Success of new research projects crucial to contain community spread of COVID-19 in India: Globaldat expresspharma
May 05, 2020
The main objectives of these projects are to develop solutions to reduce community transmission and identify novel targets with the help of metabolite biomarkers.
Pharma companies in APAC shine during Q1 2020: GlobalData expresspharma
May 04, 2020
The pharma sector registered 16.6 per cent growth as it was meeting the growing demand from healthcare services providers.
Novartis digital initiatives to create awareness of heart failure can positively impact patients’ lives in India: GlobalData expresspharma
April 15, 2020
According to GlobalData’s Pharma Intelligence Center, the diagnosed prevalence of congestive heart failure in India is currently around 9.61 million with an annual growth of 4 per cent.
Lupus pipeline sees high level of 43% first-in-class innovation biospectrumasia
August 08, 2019
GlobalData indicates translation of this high-level innovation to numerous promising first-in-class targets with strong therapeutic potential
Women are twice as likely to develop post-traumatic stress disorder than men, says GlobalData expresspharma
July 22, 2019
The number of 12-month total prevalent cases of post-traumatic stress disorder (PTSD) was higher in women than in men in the seven major markets (7MM*), with 5.5 million cases (32.05 per cent) in men compared to ...
Pfizer Takes Top Spot in Pharma Market Cap for 2018, Analysis Shows biospace
April 29, 2019
In the battle of titans, Pfizer has emerged on top as the most valuable pharma company by market cap for 2018.
R&D returns fall to lowest level in nine years: Deloitte, GlobalData biospectrumasia
December 26, 2018
‘Unlocking R&D productivity: Measuring the return from pharmaceutical innovation 2018’ published by Deloitte, reveals that returns are down 1.8 percentage points from 3.7 per cent in 2017, and forecast average peak sale.
Breast cancer clinical trials: top drugs under investigation pharmaceutical-technology
December 25, 2018
Breast cancer is the most commonly diagnosed cancer in women, the second most commonly diagnosed cancer overall, and is the fifth largest cause of cancer mortality worldwide.
Atopic dermatitis market set to almost triple in value over next 10 years pharmafile
December 13, 2018
The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page